Robots Journal

Subscribe to Robots Journal: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get Robots Journal: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

Robots Journal Authors: Automic Blog, Kevin Benedict, Julia Chernykh, Nicole Austin

Related Topics: CEOs in Technology, FDA News, Government News, Robots Journal

News Feed Item

Houston Medical Robotics, Inc. Receives FDA 510(k) Clearance for Euclid™ Tier 1 Mini Access System

HOUSTON, March 5, 2012 /PRNewswire/ -- Houston Medical Robotics, Inc. announces that it has received U.S. Food and Drug Administration 510(k) clearance to market the Euclid™ Tier 1 Mini Access System.  The Euclid™ Tier 1 Mini Access System is a portable, hand-held device that integrates commercially available ultrasound imaging systems to facilitate placement of a needle and guidewire into a targeted anatomical location for a variety of therapeutics applications. 

"Although numerous applications have been identified, our initial target for the Euclid™ Tier 1 Mini Access System is reducing complications associated with central venous catheter (CVC) placement," stated Jeffery J. Sheldon, Houston Medical Robotics, Inc. Chairman & CEO.  "With over 5 million CVCs placed each year - and published complication rates are as high as 26% - we are poised to make a significant impact on healthcare outcomes," stated Mr. Sheldon. 

Technology limitations, inadequate procedure training & exposure, and varying patient size & morphology have all been identified as co-contributors to the high CVC placement complication rates.  Use of ultrasound imaging during procedures has been shown to reduce complications; however, the procedure is cumbersome and generally requires additional assistance.  "The Euclid™ Tier 1 Mini Access System places all the necessary tools and consumables readily at hand for single-operator safe, effective, rapid, and cost-effective access," stated Mr. Sheldon.

About Houston Medical Robotics, Inc.

Houston Medical Robotics, Inc. develops & commercializes revolutionary image guided hand-held medical robotics for use in various therapeutic applications. The devices provide safer, cheaper, and more effective procedure alternatives, thereby increasing caregiver efficiency, hospital & clinic revenue, and overall patient satisfaction.  Houston Medical Robotics, Inc. raised $2.2 million from CitareTx Investment Partners I, LP, a Texas based medical device investment fund and business incubator, also founded and managed by Mr. Sheldon.  

Contact: Jeffery J. Sheldon - Founder, Chairman & CEO, Houston Medical Robotics, Inc., +1-281-984-7368 (office), +1-281-984-7374 (fax), or +1-832-455-3173 (mobile), [email protected]

SOURCE Houston Medical Robotics, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.